News | September 21, 2012

Endologix Receives CE Mark for Nellix EndoVascular Aneurysm Sealing System

Company plans for additional device enhancements, limited introduction in Europe in Q2 2013

September 21, 2012 — Endologix Inc., developer and marketer of treatments for aortic disorders, announced earlier this month it received CE mark for the current version of the Nellix EndoVascular Aneurysm Sealing System for the treatment of patients with abdominal aortic aneurysms (AAA).

Nellix is a new endovascular aneurysm sealing (EVAS) system designed to simplify endovascular procedures, treat a broader range of patients and provide enhanced clinical outcomes. The Nellix system is not approved in the United States for either investigational use or commercial sale.

Endologix is currently implementing a few enhancements to the Nellix System, intended to further optimize the device for commercialization. When complete, the company will submit these enhancements to its notified body, with expectations of gaining CE mark approval for the commercial version of the device and beginning a limited market introduction of the enhanced system in Europe by the end of the second quarter 2013.

John McDermott, Endologix president and CEO, said, "Nellix has the potential to treat more AAA patients and get better clinical outcomes than any other device for the endovascular repair of AAA. Receiving CE mark for the current version of the system is an important regulatory milestone, and we look forward to providing this technology to physicians and their patients in 2013."

For more information: www.endologix.com

Related Content

First Patient Enrolled in Gore Excluder Investigational Study
News | Stent Grafts | January 08, 2018
January 8, 2018 — W. L. Gore & Associates Inc.
FDA Concerned About Increase in stent graft Endovascular Type III Leaks
News | Stent Grafts | October 09, 2017
October 9, 2017 — The U.S.
Gore Announces First-in-Human Use of Gore TAG Conformable Thoracic Stent Graft
News | Stent Grafts | July 17, 2017
W. L. Gore & Associates Inc. announced the first patient implant of the Gore TAG Conformable Thoracic Stent Graft...
News | Stent Grafts | April 06, 2017
Endologix Inc. announced that the first patients were treated in the Expanding Patient Applicability with Polymer...
Gore, Viabahn VBX Balloon Expandable Endoprosthesis, stent graft, iliac artery, FDA approval
Technology | Stent Grafts | January 31, 2017
W. L. Gore & Associates (Gore) announced that the Gore Viabahn VBX Balloon Expandable Endoprosthesis (VBX Stent...
Lombard Medical, Aorfix endovascular stent graft, Japanese regulatory approval, IntellFlex LP Delivery System
News | Stent Grafts | January 11, 2017
January 11, 2017 — Lombard Medical Inc.
stent grafts, fluid flow model, clotting risk, Journal of Vascular Surgery

An anterior view is shown of the geometries of each of the graft configurations: (A) fenestrated, (B) antegrade branched, (C) retrograde branched, and (D) manifold stent graft. Image courtesy of Taylor Suess, et al.

News | Stent Grafts | January 05, 2017
January 5, 2017 — Whether patients with mechanical heart valves and stents must take blood thinners depends on how ef
News | Stent Grafts | December 13, 2016
Lombard Medical Inc. announced that its Altura endovascular stent graft system was featured in a scientific...
News | Stent Grafts | August 19, 2016
Endologix Inc. announced the first two patients with abdominal aortic aneurysms (AAA) have been treated with the...
bioabsorbable vascular graft, children, feasibility study, Bakoulev Center Moscow, AATS 2016 meeting

Image courtesy of Bakoulev Scientific Center for Cardiovascular Surgery

News | Stent Grafts | May 18, 2016
Bioabsorbable heart valves or blood vessels are designed to harness the body’s innate healing process, enabling the...
Overlay Init